← SynDRA
SP-600125
SynDRA canonical compound SYN0026630 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LRRK2 | MAPK10 | MAPK8 | MAPK8IP1 | MAPK9 | TTK |
|---|
| Mechanism of action | JNK inhibitor |
|---|
All known targets
- MAPK10
- MAPK8
- MAPK9
- TTK
- LRRK2
- MAPK8; MAPK9; MAPK10
- MAPK8IP1
Mechanisms of action (all sources)
- MAPK8 INHIBITOR
- TTK INHIBITOR
- MAPK10 INHIBITOR
- Inhibitor
- MAPK9 INHIBITOR
Cross-references
Synonyms
- 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
- Anthra[1,9-cd]pyrazol-6(2H)-one
- 1,9-Pyrazoloanthrone
- SP600125
- Pyrazolanthrone
- Dibenzo[cd,g]indazol-6(2H)-one
- Pyrazoleanthrone
- Anthra-1,9-pyrazol-6-none
- CI 70300
- 2H-Dibenzo[cd,g]indazol-6-one
- JNK Inhibitor II
- SAPK Inhibitor II
- NSC 75890
- UNII-1TW30Y2766
- ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE
- EINECS 204-955-6
- BRN 0746890
- CHEMBL7064
- MLS002693964
- CHEBI:90695
- ACPOUJIDANTYHO-UHFFFAOYSA-N
- 1TW30Y2766
Look up SP-600125 in the interactive SynDRA portal →